Clarithromycin pharmacokinetics in the desert tortoise (Gopherus agassizii)

Journal of Zoo and Wildlife Medicine

Volumn 30, Issue 1, 1999, Pages 36-43

  Wimsatt, Jeffrey ^a   Johnson, Jay ^a   Mangone, Bernard A ^a   Tothill, Alysa ^a   Childs, James M ^b   Peloquin, Charles A ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Clarithromycin; Desert tortoise; Gopherus agassizii; Multidose; Pharmacokinetics; Single dose

Indexed keywords

ANTIINFECTIVE AGENT; CLARITHROMYCIN;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; DESERT CLIMATE; HALF LIFE TIME; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; TURTLE; UNITED STATES;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CLARITHROMYCIN; DESERT CLIMATE; HALF-LIFE; MALE; TURTLES; UTAH;

EID: 0033087756     PISSN: 10427260     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Alder, J., T. Hutch, J. A. Meulbroek, and J. C. Clement. 1994. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 7: 1141-1148.
2. Araujo, F. G., P. Prokocimer, T. Lin, and J. S. Remington. 1992. Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. Antimicrob. Agents Chemother. 36: 2454-2457.
3. Ball, P. 1991. The future role and importance of macrolides. J. Hosp. Infect. 19(Suppl. A): 47-59.
4. Beck, K., M. Loomis, G. Lewbart, L. Spelman, and M. Papich. 1995. Preliminary comparison of plasma concentrations of gentamicin injected into the cranial and caudal limb musculature of the eastern box turtle (Terrapene carolina carolina). J. Zoo Wildl. Med. 26: 265-268.
5. Block, S., J. Hedrick, M. R. Hammerschlag, G. H. Cassell, and J. C. Craft. 1995. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr. Infect. Dis. J. 14: 471-477.
6. Brown, M. B., I. M. Schumacher, P. A. Klein, K. Harris, T. Correll, and E. R. Jacobson. 1994. Mycoplasma agassizii causes upper respiratory tract disease in the desert tortoise. Infect. Immun. 62: 4580-4586.
7. Bush, M., R. Custer, J. M. Smeller, P. Charache, and R. Arthur. 1977. Preliminary study of gentamicin in turtles. Proc. Am. Assoc. Zoo Vet. 1977: 71-78.
8. Caliguiri, R., G. V. Kollias, E. Jacobson, B. McNab, C. H. Clark, and R. C. Wilson. 1990. The effects of ambient temperature on amikacin pharmacokinetics in gopher tortoises. J. Vet. Pharmacol. Ther. 13: 287-291.
9. Chien, S. M., P. Pichotta, N. Siepman, and C. K. Chan. 1993. Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group. Chest 103: 697-701.
10. Chiou, W. L. 1989. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part 1). Clin. Pharmacokinet. 17: 175-199.
11. Clark, C. H. 1986. Pharmacology of antibiotics. In: Harrison G. J., and L. R. Harrison (eds.). Clinical Avian Medicine and Surgery. W. B. Saunders Co., Philadelphia, Pennsylvania. Pp. 319-326.
12. Conte, J. E., Jr., J. Golden, S. Duncan, E. McKenna, E. Lin, and E. Zurlinden. 1996. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Antimicrob. Agents Chemother. 40: 1617-1622.
13. Conte, J. E., J. E. Golden, S. Duncan, E. McKenna, and E. Zurlinden. 1995. Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin. Antimicrob. Agents Chemother, 39: 334-338.
14. Cranshaw, G. C., and P. Holz. 1996. Comparison of plasma biochemical values in blood and blood lymph mixtures from red-eared sliders, Trachemys scripta elegans. Bull. Assoc. Rept. Amphib. Vet. 6: 7-9.
15. Gibaldi, M., and D. Perrier (eds.). 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, New York, New York. Pp. 409-417.
16. Hardy, D. J. 1993. Extent and spectrum of the antimicrobial activity of clarithromycin. Pediatr. Infect. Dis. J. 12: S99-105.
17. Heifets, L. B. 1996. Clarithromycin against Mycobacterium avium complex infections. Tuberc. Lung Dis. 77: 19-26.
18. Hilf, M., D. Swanson, R. Wagner, and V. L. Yu. 1991. Pharmacokinetics of piperacillin in blood pythons (Python curtus) and in vitro evaluation of efficacy against aerobic gram-negative bacteria. J. Zoo Wildl. Med. 22: 199-203.
19. Ishida, K., M. Kaku, K. Irifune, R. Mizukane, H. Takemura, R. Yoshida, H. Tanaka, T. Usui, N. Suyama, K. Tomono. 1994. In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 38: 790-798.
20. Jacobson, E. R., M. B. Brown, M. Chung, K. Vilet, and R. Swift. 1988. Serum concentration and disposition kinetics of gentamicin and amikacin in juvenile American alligators. J. Zoo Anim. Med. 19: 188-194.
21. Jacobson, E. R., M. B. Brown, I. M. Schumacher, B. R. Collins, R. K. Harris, and P. A. Klein. 1995. Mycoplasmosis and the desert tortoise (Gopherus agassizii) in Las Vegas Valley, Nevada. Chelon. Conserv. Biol. 1: 279-284.
22. Jacobson, E. R., J. M. Gaskin, M. B. Brown, R. K. Harris, C. H. Gardiner, J. L. LaPointe, H. P. Adams, and C. Reggiardo. 1991. Chronic upper respiratory disease of free-ranging desert tortoises (Xerobates agassizii). J. Wildl. Dis. 27: 296-316.
23. Kanatani, M. S., and B. J. Guglielmo. 1994. The new macrolides. Azithromycin and clarithromycin. West. J. Med. 160: 31-37.
24. Kirkwood, J. K., and J. Merriam. 1990. Variation in plasma half-life of gentamicin between species in relation to bodyweight and taxonomy. Res. Vet. Sci. 39: 160-165.
25. Klingenberg, R. J., and B. Backner. 1994. International Herpetological Symposium on Captive Propagation Husbandry. Assoc. Br. Wild Anim. Keepers, Bristol, England. Pp. 127-140.
26. Lawrence, K., P. W. Muggleton, and J. R. Needham. 1984. Preliminary study on the use of ceftazidime, a broad spectrum cephalosporin antibiotic, in snakes. Res. Vet. Sci. 36: 16-20.
27. Lawrence, K., J. R. Needham, G. H. Palmer, and J. C. Lewis. 1984. A preliminary study on the use of carbenicillin in snakes. J. Vet. Pharmacol. Ther. 7: 119-124.
28. Lawrence, K., G. H. Palmer, and J. R. Needham. 1986. Use of carbenicillin in two species of tortoise (Testudo graeca and T. hermanni). Res. Vet. Sci. 40: 413-415.
29. Low, G. 1977. Absorption and distribution of drugs in amphibians and reptiles (frog, Testudo harmanni, Python molurus) at various body temperatures. Ph.D. Dissertation, Ludwig Maximillian Universitat, Munich, Germany.
30. Mader, D. R., G. M. Conzelman, Jr., and J. D. Baggot. 1985. Effects of ambient temperature on the half-life and dosage regimen of amikacin in the gopher snake (Pituophis melanoleucus catenifer). J. Am. Vet. Med. Assoc. 187: 1134-1136.
31. Manitpisitkul, P., and W. L. Chiou. 1993. Intravenous verapamil kinetics in rats: marked arteriovenous concentration difference and comparison with humans. Biopharm. Drug Dispos. 14: 555-566.
32. McEvoy, G. K. 1996. (Ed.) American Hospital Formulary Service Drug Information, 1996 ed. American Society of Health Systems Pharmacists, Bethesda, Maryland. Pp. 231-232.
33. Montali, R. J., M. Bush, and J. M. Smeller. 1979. The pathology of nephrotoxicity of gentamicin in snakes. A model for reptilian gout. Vet. Pathol. 16: 108-115.
34. Patel, K. B., D. Xuan, P. R. Tessier, J. H. Russomanno, R. Quintiliani, and C. H. Nightingale. 1996. Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrob. Agents Chemotherapy. 40: 2375-2379.
35. Peloquin, C. A. 1997. Mycobacterium avium complex infection: pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes. Clin. Pharmacokinet. 32: 132-44.
36. Prezant, R. M., R. Isaza, and E. R. Jacobson. 1994. Plasma concentrations and disposition kinetics of enrofloxacin in gopher tortoises (Gopherus polyphemus). J. Zoo Wildl. Med. 25: 82-87.
37. Raphael, B. L., M. Papich, and R. A. Cook. 1994. Pharmacokinetics of enrofloxacin after a single intramuscular injection in Indian star tortoises (Geochelone elegans). J. Zoo Wildl. Med. 25: 88-94.
38. Ritchie, D. J., A. W. Hopefl, T. W. Milligan, J. E. Byrne, and M. S. Maddux. 1993. In vitro activity of clarithromycin, cefprozil, and other common oral antimicrobial agents against gram-positive and gram-negative pathogens. Clin. Ther. 15: 107-113.
39. Spörle, H. 1992. Untersuchungen zu den blutspiegelverlaufen der antiinfektiva ampicillin, doxycyclin und enrofloxacin bei der griechischen landschildkrote (Testudo hermanni). Ph.D. Dissertation, Justus Liebig Universitat, Giesen, Germany.
40. Walker, K. J., A. J. Larsson, R. A. Zabinski, and J. C. Rotschafer. 1994. Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 38: 2003-2007.
41. Wimsatt, J., J. D. Johnson, and B. A. Mangone. 1996. A cardiac access port for repeated sampling in the desert tortoise (Gopherus agassizii). Curr. Trends Lab. Anim. Sci. 37: 101-103.
42. Young, L. A., J. Schumacher, M. G. Papich, and E. R. Jacobson. 1997. Disposition of enrofloxacin and its metabolite ciprofloxacin after intramuscular injection in juvenile Burmese pythons (Python molurus bivittatus). J. Zoo Wildl. Med. 28: 71-79.